Evidence map›Paper›PMID 23068074›Full record

ReviewMolecular aspects of medicine2013

Innate immune activation in obesity.

Carey N Lumeng

Open access · greenAbstract readReview
In one paragraph

Review in Molecular aspects of medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 2 syntheses or guidelines pooled it, 145 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Insulin sensitizing and anti-inflammatory effects of thiazolidinediones are heightened in obese patients.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2013
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Probiotic and high-fat diet: effects on pain assessment, body composition, and cytokines in male and female adolescent and adult rats.American journal of physiology. Regulatory, integrative and comparative physiology · 2024
    Article
  12. Article
  13. Obesity Duration and Cardiometabolic Disease.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Potential ofCells · 2022
    Review
  19. Article
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Carey N LumengDepartment of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, MI, United States. clumeng@umich.ed
University of Michigan–Ann Arbor · US

Funding

Regulation of Adipose Tissue Inflammation By Antigen Presenting CellsR01DK090262 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, CAREY N · 2011 to 2024
$5.3M
Adipose tissue macrophage polarization and its influence on adipocyte functionK08DK078851 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, CAREY N · 2007 to 2011
$705k
Real Time Visualization of Obesity-Induced Inflammation in Adipose TissueR21DK092873 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, CAREY N · 2011 to 2012
$428k
NIDDK NIH HHS DK078851NIDDK NIH HHS DK090262NIDDK NIH HHS K08 DK078851NIDDK NIH HHS R01 DK090262NIDDK NIH HHS R21 DK092873
6 · The paper itself

Abstract

The innate immune system is a prewired set of cellular and humoral components that has developed to sense perturbations in normal physiology and trigger responses to restore the system back to baseline. It is now understood that many of these components can also sense the physiologic changes that occur with obesity and be activated. While the exact reasons for this chronic immune response to obesity are unclear, there is strong evidence to suggest that innate inflammatory systems link obesity and disease. Based on this, anti-inflammatory therapies for diseases like type 2 diabetes and metabolic syndrome may form the core of future treatment plans. This review will highlight the components involved in the innate immune response and discuss the evidence that they contribute to the pathogenesis of obesity-associated diseases.

Indexed as

Immunity, InnateAnti-Inflammatory AgentsDiabetes Mellitus, Type 2Fatty LiverHumansInflammationMetabolic SyndromeNon-alcoholic Fatty Liver DiseaseObesityAnti-Inflammatory Agents

Identifiers

PMID23068074
PMCPMC3888776
OpenAlexW2003282625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.